Deltex Medical Group plc

DTXMFOTCHealthcare

$0.10

+$0.00(+0.00%)

Market Cap$180577488

P/E Ratio—

52W High$0.09524

52W Low$0.0013

Avg Volume32K

Open$0.10

Beta-2.39

Overview

Deltex Medical Group plc (DTXMF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

DTXMF · earnings · updated Jun 9, 2026

Latest Earnings

Q3 FY2024Report Date: Sep 23, 2024

EPS Actual

-$0.00

Revenue

$0.00B

Fiscal Period

Q3 FY2024

FY ends December

Report Date

Sep 23, 2024

After Market Close

DTXMF reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

$3.83

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.$3.83

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Sep 22, 2026	—	—	—	—	—	—
◌ Q3 FY2026	Sep 22, 2026	—	—	—	—	—	—
◌ Q2 FY2026	Apr 2, 2026	—	—	—	—	—	—
◌ Q2 FY2026	Apr 2, 2026	—	—	—	—	—	—
◌ Q3 FY2025	Sep 22, 2025	—	—	—	—	—	—
◌ Q1 FY2025	Mar 31, 2025	—	—	—	—	—	—
— Q3 FY2024	Sep 23, 2024	—	-$0.00	—	$0.00B	—	—
— Q2 FY2023	Jun 30, 2023	—	-$0.00	—	$0.00B	$0.00B	-4.0%

Q3 FY2026

Sep 22, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2026

Sep 22, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2026

Apr 2, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2026

Apr 2, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2025

Sep 22, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2025

Mar 31, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2024

Sep 23, 2024

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q2 FY2023

Jun 30, 2023

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Analyst Estimates

EPS Estimates

Period	Low	Consensus	High	# Analysts

Revenue Estimates

Period	Low	Consensus	High	# Analysts

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q3 FY2024	Sep 23, 2024	—	$0.00	—	—
— Q2 FY2023	Jun 30, 2023	—	$0.01	$0.01	+0.00%
— Q4 FY2022	Dec 31, 2022	—	$0.01	$0.01	+0.00%
— Q2 FY2022	Jun 30, 2022	—	$0.00	$0.00	+0.00%
— Q4 FY2021	Dec 31, 2021	—	$0.03	$0.03	+0.00%
— Q2 FY2021	Jun 30, 2021	—	$0.03	$0.03	+0.00%

Q3 FY2024—

Report Date

Sep 23, 2024

EPS Beat/Miss

—

Price Before

$0.00

Price After

—

Q2 FY2023+0.00%

Report Date

Jun 30, 2023

EPS Beat/Miss

—

Price Before

$0.01

Price After

$0.01

Q4 FY2022+0.00%

Report Date

Dec 31, 2022

EPS Beat/Miss

—

Price Before

$0.01

Price After

$0.01

Q2 FY2022+0.00%

Report Date

Jun 30, 2022

EPS Beat/Miss

—

Price Before

$0.00

Price After

$0.00

Q4 FY2021+0.00%

Report Date

Dec 31, 2021

EPS Beat/Miss

—

Price Before

$0.03

Price After

$0.03

Q2 FY2021+0.00%

Report Date

Jun 30, 2021

EPS Beat/Miss

—

Price Before

$0.03

Price After

$0.03

Beat Rate0 / 6 quarters

Largest Move+0.00% (Q2 FY2023)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Deltex Medical Group plc (DTXMF) most recently reported earnings on September 23, 2024 for Q3 FY2024, posting EPS of $-0.00 (in line with the analyst consensus of —). The next DTXMF earnings date is expected around September 1, 2026.

Each quarter, investors track DTXMF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DTXMF revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

DTXMF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

DTXMF earnings · 4 questions

Deltex Medical Group plc's next earnings report is expected around September 1, 2026. DTXMF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DTXMF historically reports after market close (AMC).

DTXMF earnings datewhen is DTXMF earningsDTXMF next earnings datewhen does DTXMF report earningsDTXMF earnings calendar

▸ Source: FMP · Deltex Medical Group plc SEC filings · US GAAP · Deltex Medical Group plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026